Atrial fibrillation

Primary Care - Clinics in Office Practice

Volumn 32, Issue 4, 2005, Pages 1083-1107

  Ziv, Ohad ^a,b   Choudhary, Gaurav ^a,c  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; ESMOLOL; FLECAINIDE; IBUTILIDE; METOPROLOL; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN; XIMELAGATRAN;

ANTICOAGULATION; BRADYCARDIA; BRONCHOSPASM; CARDIOVERSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIGOXIN BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG FATALITY; ELECTROCARDIOGRAM; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART PACING; HEART SURGERY; HEART VENTRICLE TACHYCARDIA; HISTORY; HOSPITALIZATION; HUMAN; HYPOTENSION; LIVER TOXICITY; LUNG TOXICITY; LUPUS ERYTHEMATOSUS; META ANALYSIS; PACEMAKER; PATHOPHYSIOLOGY; PHOTOSENSITIVITY; POLYNEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; QT INTERVAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; SINUS RHYTHM; STROKE; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; THROMBOEMBOLISM; THYROID DISEASE; TORSADE DES POINTES; TREATMENT INDICATION; URINE RETENTION; XEROSTOMIA;

ADRENERGIC BETA-ANTAGONISTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; DECISION TREES; ELECTRIC COUNTERSHOCK; HEART RATE; HUMANS; PRIMARY HEALTH CARE; PROGNOSIS; RECURRENCE;

EID: 28444486517     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2005.09.003     Document Type: Review

References (68)

1. V. Fuster, L.E. Ryden, and R.W. Asinger ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation J Am Coll Cardiol 8 4 2001 1266i-lxx
2. L.D. Ostrander Jr., R.L. Brandt, and M.O. Kjelsberb Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan Circulation 31 1965 888 898
3. S.J. Phillips, J.P. Whisnant, and M.W. O'Fallon Prevalence of cardiovascular disease and diabetes in residents of Rochester Mayo Clin Proc 65 1990 344 357
4. A. Jahangir, T.M. Munger, and D.L. Packer Atrial fibrillation P.J. Podrid P.R. Kowey Cardiac arrhythmias: mechanisim, diagnosis, and management 2001 Lippincott Williams & Wilkins Philadelphia 457 499
5. W.B. Kannel, R.D. Abbott, and D.D. Savage Epidemiological features of chronic atrial fibrillation; the Framingham Study N Engl J Med 306 1982 1018 1022
6. C.D. Furberg, M. Psaty Bruce, and T.A. Manolio Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) Am J Cardiol 74 1994 236 241
7. E.J. Benjamin, D. Levy, and S.M. Vaziri Independent risk factors for atrial fibrillation in a population-based cohort, the Framingham Heart Study JAMA 271 11 1994 840 844
8. T.S. Tsang, G.W. Petty, and M.E. Barnes The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota; changes over three decades J Am Coll Cardiol 42 1 2003 93 100
9. R. Mandapati, A. Skanes, and J. Chen Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart Circulation 101 2000 194 199
10. A. Skanes, R. Mandapati, and O. Berenfeld Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart Circulation 98 1998 1236 1248
11. M. Haissaguerre, P. Jais, and D.C. Shah Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 10 1998 659 666
12. R. Cappato, H. Calkins, and S.-A. Chen Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circulation 111 2005 1100 1105
13. R.H. Falk Atrial Fibrillation N Engl J Med 344 14 2001 1067 1078
14. C.B. Upshaw Jr. Hemodynamic changes after cardioversion of chronic atrial fibrillation Arch Intern Med 157 1997 1070 1076
15. W. Kannel, R. Abbott, and D. Savage Coronary heart disease and atrial fibrillation: the Framingham Study Am Heart J 106 1985 386 396
16. S. Levy, M. Maarek, and P. Coumel Characterization of different subsets of atrial fibrillation Circulation 99 1999 3028 3035
17. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 8 1991 983 988
18. R. Hart, L. Pearce, and R. McBride Factors associated with ischemic stroke during aspirin therapy in atrial fiibrillation: analysis of 2012 participants in the SPAF I-III clinical trials Stroke 30 2005 1223 1229
19. F. Bogun, D. Anh, and G. Kalahasty Misdiagnosis of atrial fibrillation and its consequences Am J Med 117 2004 636 642
20. P.G. Danias, T.A. Caulfield, and M.J. Weigner Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm J Am Coll Cardiol 31 3 1998 588 592
21. K.A. Ellenbogen, V.C. Dias, and V.J. Plumb A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-heart rate control during atrial fibrillation and atrial flutter: a multicenter study J Am Coll Cardiol 18 1991 891 897
22. R. Rinkenberger, E. Prystowsky, and J. Heger Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrythmias Circulation 62 1980 996 1010
23. F. Jung, and J.P. DiMarco Treatment strategies for atrial fibrillation Am J Med 104 1998 272 286
24. K. Koh, K. Kwon, and H. Park Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation Am J Cardiol 75 1995 88 90
25. U. Shettigar, J. Toole, and D. Appunn Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter Am Heart J 126 1993 368 374
26. F.A. Masoudi, and N. Goldschlager The medical management of atrial fibrillation Cardiol Clin 15 4 1997 689 719
27. G.C. Flaker, K.A. Fletcher, and R.M. Rothbart Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation Am J Cardiol 76 1995 355 358
28. D. Fatkin, D.L. Kuchar, and C.W. Thorburn Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications J Am Coll Cardiol 23 2 1994 307 316
29. M.J. Weigner, T.A. Caulfield, and P.G. Danias Risk of clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours Ann Intern Med 126 1997 615 620
30. G. Lip, A. Rumley, and F. Dunn Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm Int J Cardiol 51 1995 245 251
31. W.J. Manning, D.I. Silverman, and S.P.F. Gordon Cardioversion from atrial fibrilation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence pf atrial thrombi N Engl J Med 328 11 1993 750 755
32. C.R. Asher, and A.L. Klein Transesophageal echocardiography to guide electrical cardioversion in atrial fibrillation Cleve Clin J Med 69 9 2002 713 718
33. I. Van Gelder, H. Crijns, and R. Tielman Chronic atrial fibrillation: success of serial cardiovascular therapy and safety of oral anticoagulation Arch Intern Med 156 1996 2585 2592
34. D. Echt, P. Leibson, and B. Mitchell Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the CArdiac Arrhythmia Suppression Trial N Engl J Med 324 12 1991 781 788
35. K. Murray Ibutilide Circulation 97 5 1998 493 497
36. P. Ziegler, and J. Koehler Atrial arrhythmias are frequently undetected by intermittent 24-hour monitoring [abstract 1058-266] J Am Coll Cardiol 453 Suppl A 2005 13A
37. A. Terzi, G. Furlan, and P. Chiavacci Prevention of atrial tachyarrhythmias after non-cardiac thoracic surgery by infusion of magnesium sulfate Thorac Cardiovasc Surg 44 6 1996 300 303
38. J.P. Mathew, M.L. Fontes, and I.C. Tudor A multicenter risk index for atrial fibrillation after cardiac surgery JAMA 291 14 2004 1720 1728
39. O. Wazni, D. Martin, and N. Marrouche Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery Circulation 110 2 2004 124 127
40. V. Salaria, N.J. Mehta, and S. Abdul-Aziz Role of postoperative use of adrenergic drugs in occurrence of atrial fibrillation after cardiac surgery Clin Cardiol 28 3 2005 131 135
41. T. Andrews, S. Reimold, and J. Berlin Prevention of supraventricular arrythmias after coronary artery bypass surgery: a meta-analysis of randomized control trials Circulation 84 1991 236 244
42. E. Daoud, S. Strickberger, and K. Man Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery N Engl J Med 337 1997 1785 1791
43. T. Guarnieri, S. Nolan, and S. Gottlieb Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial J Am Coll Cardiol 34 1999 343 347
44. D. Stebbins, L. Igidbashian, and S. Goldman Clinical outcome of patients who develop atrial fibrillation after coronary artery bypass graft surgery Pacing and Clinical Electrophysiology: PACE 18 1995 798 [Abstract]
45. The atrial fibrillation follow-up investigation of rhythm management (AFFIRM) investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 23 2002 1825 1833
46. I. Van Gelder, V. Hagens, and H. Bosker A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 23 2002 1834 1840
47. The atrial fibrillation follow-up investigation of rhythm management (AFFIRM) investigators Relationship between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study Circulation 109 2004 1509 1513
48. R.J. Shelton The AFFIRM study: approaches to control rate in atrial fibrillation J Am Coll Cardiol 44 12 2004 2418 2419
49. M.C. Fang, and D.E. Singer Anticoagulation for atrial fibrillation Cardiol Clin 22 2004 47 62
50. I.C. Van Gelder, M. Rienstra, and M.P. Van den Berg Rate control in atrial fibrillation J Am Coll Cardiol 44 12 2004 2417 2418
51. E. Hylek, S. Skates, and M. Sheehan An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with non-rheumatic atrial fibrillation N Engl J Med 335 1996 540 546
52. Stroke Prevention in Atrial Fibrillation investigators Stroke Prevention in Atrial Fibrillation study Circulation 84 2 1991 527 539
53. Stroke Prevention in Atrial Fibrillation investigators Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II study Lancet 343 1994 687 691
54. S. Olson Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial Lancet 362 2003 1691 1698
55. V. Gurewich Ximelagatran - promises and concerns JAMA 293 6 2005 736 739
56. B.F. McBride A preliminary assessment of the critical differences between novel oral anticoagulants currently in development J Clin Pharmacol 45 9 2005 1004 1017
57. R. Hart, O. Benavente, and R. McBride Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 2005 492 501
58. J.B. Segal, R.L. McNamara, and M.R. Miller Prevention of thromboembolism in atrial fibrillation: a meta-analysis of trials of anticoagulants and antiplatelet drugs J Gen Intern Med 15 2000 56 67
59. Atrial fibrillation investigators The efficacy of aspirin inpatients with atrial fibrillation: analysis of pooled data from three randomized trials Arch Intern Med 157 1997 1237 1240
60. D. Roy, M. Talajic, and P. Dorian Amiodarone to prevent recurrence of atrial fibrillation N Engl J Med 342 13 2005 913 920
61. N. Igoumenidis, G. Kocchiadakis, and M. Hamilos Propafenone-sotalol: which is prefered in atrial fibrillation, for the maintenance of normal sinus rhythm [abstract 1021-251] J Am Coll Cardiol 453 Suppl A 2005 92A
62. C. Pratt, S. Singh, and H.B.J. Al-Khalidi The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction J Am Coll Cardiol 43 7 2004 1211 1216
63. O.D. Pederson, H. Bagger, and L. Kober Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 1999 376 380
64. E. Vermes, J.C. Tardif, and M.G. Bourassa Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials Circulation 107 2003 2926 2931
65. M. Wood, C. Brown-Mahoney, and G. Kay Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis Circulation 101 2000 1138 1144
66. E. Fischer, H. Omran, and L. Thuesen Left atrial appendage occlusion to prevent stroke in sub-optimal warfarin candidates: current results of the European Multicenter Registry Trial [abstract 1116-6] J Am Coll Cardiol 453 Suppl A 2005 14A
67. H. Omran, H. Schmidt, and C. Hammerstingl Percutaneous occlusion of the left atrial appendage: cerebral magnetic resonance imaging to determine long term risk of cerebral embolism after the procedure [abstract 1078-261] J Am Coll Cardiol 453 Suppl A 2005 101A
68. P.S. Chen CACAF study Heart Rhythm 2 6 2005 678 679